Taipei, Taiwan

Shih-Hsien Chuang

USPTO Granted Patents = 18 



Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 33(Granted Patents)


Location History:

  • Xizhi, TW (2011)
  • Taoyuan, TW (2015 - 2021)
  • New Taipei, TW (2014 - 2024)
  • Taipei, TW (2021 - 2024)

Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):

Title: Contributions of Shih-Hsien Chuang to Biotechnology and Patent Innovations

Introduction: Shih-Hsien Chuang is an accomplished inventor based in New Taipei, Taiwan, known for his significant contributions to the field of biotechnology. With a robust portfolio of 18 patents, he has played a pivotal role in the development of innovative solutions, particularly in the realm of therapeutic applications.

Latest Patents: Among his notable patents, one stands out: a gas phase filter related to antibody-drug conjugates that contain an anti-mesothelin antibody. This invention provides an immunoconjugate comprising an antibody with an antigen-binding fragment that specifically targets an epitope in mesothelin. The design integrates an N-glycan binding domain and an N-glycan linked to a payload A and a payload B, which may be identical or distinct. Furthermore, the disclosure encompasses a pharmaceutical composition that utilizes the immunoconjugate along with methods for treating cancer, underscoring its potential impact in oncology.

Career Highlights: Shih-Hsien Chuang has significantly contributed to various organizations, primarily Ye Siang Enterprise Co., Ltd. and the Development Center for Biotechnology. His work in these industries highlights his dedication to advancing biotechnological research and applications.

Collaborations: Throughout his career, Chuang has collaborated with esteemed colleagues such as Shih-Chieh Chuang and Wei-Kuo Kong. These partnerships have likely enhanced the breadth and depth of his research and innovations, fostering a collaborative environment conducive to groundbreaking discoveries.

Conclusion: Shih-Hsien Chuang's dedication to innovation is evidenced by his extensive patent portfolio and collaborative efforts in biotechnology. His latest advancements, particularly in therapeutic applications, hold promise for significant contributions to cancer treatment and broader medical applications. As the field continues to evolve, Chuang’s work remains influential in paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…